Vicus Capital Johnson & Johnson Transaction History

Vicus Capital

$1.1 Billion
Q2 2024

A detailed history of Vicus Capital transactions in Johnson & Johnson stock. As of the latest transaction made, Vicus Capital holds 6,870 shares of JNJ stock, worth $1.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

6,870

Previous 7,076 2.91%

Holding current value

$1.1 Million

Previous $1.12 Million 10.28%

% of portfolio

0.09%

Previous 0.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$144.38 - $157.78 $29,742 - $32,502	-206 Reduced 2.91%	6,870 $1 Million
Q1 2024 Apr 17, 2024	BUY	$155.22 - $162.74 $132,868 - $139,305	856 Added 13.76%	7,076 $1.12 Million
Q4 2023 Feb 01, 2024	SELL	$145.6 - $158.88 $240,676 - $262,628	-1,653 Reduced 21.0%	6,220 $974,000
Q3 2023 Oct 23, 2023	BUY	$155.75 - $174.48 $268,045 - $300,280	1,721 Added 27.97%	7,873 $1.23 Million
Q2 2023 Aug 17, 2023	SELL	$154.35 - $166.11 $60,813 - $65,447	-394 Reduced 6.02%	6,152 $1.02 Million
Q1 2023 May 02, 2023	SELL	$151.05 - $180.26 $33,079 - $39,476	-219 Reduced 3.24%	6,546 $1.01 Million
Q4 2022 Feb 15, 2023	SELL	$160.2 - $179.79 $990,035 - $1.11 Million	-6,180 Reduced 47.74%	6,765 $1.2 Million
Q3 2022 Nov 08, 2022	BUY	$161.33 - $179.52 $866,664 - $964,381	5,372 Added 70.94%	12,945 $2.12 Million
Q2 2022 Aug 10, 2022	BUY	$168.19 - $186.01 $151,875 - $167,967	903 Added 13.54%	7,573 $1.34 Million
Q1 2022 May 11, 2022	BUY	$158.14 - $179.59 $11,386 - $12,930	72 Added 1.09%	6,670 $1.18 Million
Q4 2021 Feb 10, 2022	BUY	$155.93 - $173.01 $1.03 Million - $1.14 Million	6,598 New	6,598 $1.14 Million
Q2 2021 Aug 10, 2021	SELL	$159.48 - $171.07 $1.26 Million - $1.35 Million	-7,911 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$153.07 - $170.48 $73,473 - $81,830	480 Added 6.46%	7,911 $1.3 Million
Q4 2020 Feb 01, 2021	SELL	$137.11 - $157.38 $17,001 - $19,515	-124 Reduced 1.64%	7,431 $1.17 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $45,763 - $50,148	-326 Reduced 4.14%	7,555 $1.13 Million
Q2 2020 Aug 03, 2020	SELL	$128.81 - $155.51 $34,907 - $42,143	-271 Reduced 3.32%	7,881 $1.11 Million
Q1 2020 May 07, 2020	SELL	$111.14 - $153.99 $94,357 - $130,737	-849 Reduced 9.43%	8,152 $1.07 Million
Q4 2019 Feb 04, 2020	SELL	$127.5 - $146.44 $760,665 - $873,661	-5,966 Reduced 39.86%	9,001 $1.31 Million
Q3 2019 Nov 18, 2019	SELL	$126.95 - $142.14 $23,104 - $25,869	-182 Reduced 1.2%	14,967 $1.94 Million
Q2 2019 Aug 08, 2019	BUY	$131.15 - $144.24 $32,000 - $35,194	244 Added 1.64%	15,149 $2.11 Million
Q1 2019 May 02, 2019	BUY	$125.72 - $139.79 $73,169 - $81,357	582 Added 4.06%	14,905 $2.08 Million
Q4 2018 Feb 07, 2019	SELL	$122.84 - $147.84 $1,228 - $1,478	-10 Reduced 0.07%	14,323 $1.85 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $21,276 - $25,004	-175 Reduced 1.21%	14,333 $1.98 Million
Q2 2018 Aug 02, 2018	SELL	$119.4 - $131.76 $76,654 - $84,589	-642 Reduced 4.24%	14,508 $1.76 Million
Q1 2018 May 07, 2018	SELL	$125.1 - $148.14 $267,463 - $316,723	-2,138 Reduced 12.37%	15,150 $1.94 Million
Q4 2017 Jan 25, 2018	SELL	$131.22 - $143.62 $118,491 - $129,688	-903 Reduced 4.96%	17,288 $2.42 Million
Q3 2017 Oct 27, 2017	BUY	$129.47 - $135.38 $2.36 Million - $2.46 Million	18,191	18,191 $2.37 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vicus Capital, based on Form 13F filings with the SEC.

News

Stay updated on Vicus Capital with notifications on news.

Account